Dodecanol

Dodecanol

SCHEMBL5182014

CCCCCCCCCCCCO.O=[PH](O)O.O=[PH](O)O

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.72
ALDH1A1 P00352 3/20 0.72
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
LMNA P02545 2/20 0.72
HSD17B10 Q99714 2/20 0.72
SMN1; SMN2 Q16637 1/20 0.67
THRB P10828 2/20 0.44
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
HTT P42858 1/20 0.41
DNM1 Q05193 1/20 0.41
MAPT P10636 1/20 0.41
PPARG P37231 3/20 0.40
PPARD Q03181 3/20 0.40
PPARA Q07869 3/20 0.40
GPR84 Q9NQS5 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
SLC22A6 Q4U2R8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cetyl Alcohol SCHEMBL5576621 1.00 TSHR (0.72) TSHRALDH1A1MEN1KMT2ALMNA
Decanol SCHEMBL28609377 1.00 TSHR (0.72) TSHRALDH1A1MEN1KMT2ALMNA
Tridecan-1-Ol SCHEMBL28168114 1.00 TSHR (0.72) TSHRALDH1A1MEN1KMT2ALMNA
Octanol SCHEMBL6433191 1.00 TSHR (0.72) TSHRALDH1A1MEN1KMT2ALMNA
Undecanol SCHEMBL5576165 1.00 TSHR (0.72) TSHRALDH1A1MEN1KMT2ALMNA
Decanol SCHEMBL25345185 1.00 TSHR (0.72) TSHRALDH1A1MEN1KMT2ALMNA
Docosanol SCHEMBL28247504 1.00 TSHR (0.72) TSHRALDH1A1MEN1KMT2ALMNA
1-Pentanol SCHEMBL10796803 0.97 SMN1; SMN2 (0.71) TSHRALDH1A1MEN1KMT2ALMNA
Butyl Alcohol SCHEMBL10796627 0.88 ALDH1A1 (0.69) TSHRALDH1A1MEN1KMT2ALMNA
Tetradecane SCHEMBL8985863 0.88 TSHR (0.57) TSHRALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328350-B1 PREPARATION CONTAINING ODOUR-STABLE OCTOCRYLENE BEIERSDORF AG (DE) 2019-09-11 EP claimed
US-20250387312-A1 COSMETIC FORMULATIONS COMPRISING A BIOPOLYMER 11584022 CANADA INC. (CA) 2025-12-25 US disclosed
EP-4665294-A1 ANTI-WRINKLE SKINCARE COMPOSITION COMPRISING A STABLE HOMOGENEOUS AQUEOUS SUSPENSION OF BIOPOLYMERS 11584022 Canada Inc. (CA) 2025-12-24 EP disclosed
EP-4661673-A1 ANTIMICROBIALLY ACTIVE PRODUCT B. Braun Melsungen AG (DE) 2025-12-17 EP disclosed
EP-4661968-A1 DIHYDROTRIAZINE COMPOUND AND COMPOSITION FOR USE IN PODOLOGY, IN THE PROPHYLAXIS AND/OR TREATMENT OF FOOT DISORDERS, THE TREATMENT OF TATTOOS AND/OR TATTOO WOUNDS AND THE TREATMENT OF A PIERCING AND/OR PIERCING WOUNDS B. Braun Melsungen AG (DE) 2025-12-17 EP disclosed
EP-4661674-A1 ANTIMICROBIAL MEDICAL PRODUCT B. Braun Melsungen AG (DE) 2025-12-17 EP disclosed
EP-4547194-A1 COSMETIC FORMULATIONS COMPRISING STABLE HOMOGENEOUS AQUEOUS SUSPENSION OF BIOPOLYMERS 11584022 Canada Inc. (CA) 2025-05-07 EP disclosed
EP-4477212-A1 BLUE-LIGHT ABSORBING COMPOUNDS AND COMPOSITIONS Esencias Moles, S.A. (ES) 2024-12-18 EP disclosed
US-20240374624-A1 NOVEL USE OF AT LEAST A HUMAN MILK OLIGOSACCHARIDE DSM IP ASSETS B.V. (NL) 2024-11-14 US disclosed
WO-2024170955-A1 ANTI-WRINKLE SKINCARE COMPOSITION COMPRISING A STABLE HOMOGENEOUS AQUEOUS SUSPENSION OF BIOPOLYMERS 11584022 CANADA INC. (CA) 2024-08-22 WO disclosed
EP-3964211-A1 A COMPOSITION COMPRISING AN ASCORBYL PHOSPHATE, NIACINAMIDE AND ALLANTOIN FOR TREATING ACNE DSM IP Assets B.V. (NL) 2022-03-09 EP disclosed
US-20220062132-A1 ODOR-STABLE ETHANOLIC PREPARATION CONTAINING OCTOCRYLENE BEIERSDORF AG (DE) 2022-03-03 US disclosed
EP-3923900-A1 ODOR-STABLE ETHANOLIC PREPARATION CONTAINING OCTOCRYLENE Beiersdorf AG (DE) 2021-12-22 EP disclosed
WO-2020164905-A1 ODOR-STABLE ETHANOLIC PREPARATION CONTAINING OCTOCRYLENE BEIERSDORF AG (DE) 2020-08-20 WO disclosed
EP-3328350-A1 PREPARATION CONTAINING ODOUR-STABLE OCTOCRYLENE Beiersdorf AG (DE) 2018-06-06 EP disclosed
WO-2017016840-A1 PREPARATION CONTAINING ODOUR-STABLE OCTOCRYLENE BEIERSDORF AG (DE) 2017-02-02 WO disclosed
EP-1408912-B1 TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS DOW CORNING (US) 2007-03-07 EP disclosed
EP-1408912-A2 TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS Dow Corning Corporation (US) 2004-04-21 EP disclosed
WO-2003009819-A2 TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS DOW CORNING CORPORATION (US) 2003-02-06 WO disclosed
US-6498197-B1 Temperature insensitive one-phase microemulsions DOW CORNING CORPORATION 2002-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250387312-A1 COSMETIC FORMULATIONS COMPRISING A BIOPOLYMER COL2A1, COL1A1, COL14A1 TSHR 4088/4885ALDH1A1 1581/4885MEN1 2680/4885
US-20220062132-A1 ODOR-STABLE ETHANOLIC PREPARATION CONTAINING OCTOCRYLENE OR51E2, CUTA, OR10J3 TSHR 3561/4885ALDH1A1 71/4885MEN1 637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.